Alder Therapeutics

Alder Therapeutics is a virtual preclinical stem cell therapy development company that is shaping the future of regenerative medicine. Founded in 2022 by three seasoned cell therapy and industry experts, the company has two promising allogeneic stem cell therapy programs in the pipeline: one for degenerative eye diseases, and one for chronic heart disease. At the core of the company’s success is the AlderEdge platform — a novel approach to cell therapy development that keeps the commercial product in mind from the start for a de-risked route to success.